Latest News

Non-Celiac Gluten/Wheat Sensitivity Affects 1 in 10 Globally, Often with Comorbid IBS
Non-Celiac Gluten/Wheat Sensitivity Affects 1 in 10 Globally, Often with Comorbid IBS

October 30th 2025

One in ten adults report NCGWS, frequently coexisting with IBS, anxiety, or depression, suggesting a central role for the gut-brain axis in pathophysiology.

FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment / Image credit: ©unlimit3d/AdobeStock
FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment

October 14th 2025

FDA OKs Subcutaneous Guselkumab Regimen for Ulcerative Colitis: Daily Dose / image credit: ©New Africa/AdobeStock
FDA OKs Subcutaneous Guselkumab Regimen for Ulcerative Colitis: Daily Dose

October 14th 2025

FDA Approves Guselkumab as First IL-23 Inhibitor With Fully Subcutaneous Regimen for Ulcerative Colitis / Image credit: ©muhammed/AdobeStock
FDA Approves Guselkumab as First IL-23 Inhibitor With Fully Subcutaneous Induction Regimen for Ulcerative Colitis

September 22nd 2025

FIT Tests, Direct Mailed, Increase Initiation of CRC Screening in Adults Aged 45 to 49 / image credit University of Southern California, Artin Galoosian, MD, MA
FIT Tests, Direct Mailed, Increase Initiation of CRC Screening in Adults Aged 45 to 49

August 5th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.